Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/50737
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12500]
Metadata
Show full item record
RESEARCH PRIORITIES FOR AN HIV CURE: INTERNATIONAL AIDS SOCIETY GLOBAL SCIENTIFIC STRATEGY 2021
Author
Deeks, Steven G.
Archin, Nancie
Cannon, Paula
Collins, Simon
Jones, R. Brad
Jong, Marein A. W. P. de
Lambotte, Olivier
Lamplough, Rosanne
Ndung’u, Thumbi
Sugarman, Jeremy
Tiemessen, Caroline T.
Vandekerckhove, Linos
Lewin, Sharon R.
Cortês, Fernanda Heloisa
The International Society Global Scientific Strategy 2021
Archin, Nancie
Cannon, Paula
Collins, Simon
Jones, R. Brad
Jong, Marein A. W. P. de
Lambotte, Olivier
Lamplough, Rosanne
Ndung’u, Thumbi
Sugarman, Jeremy
Tiemessen, Caroline T.
Vandekerckhove, Linos
Lewin, Sharon R.
Cortês, Fernanda Heloisa
The International Society Global Scientific Strategy 2021
Affilliation
University of California San Francisco. San Fransisco, CA, USA.
University of North Carolina at Chapel Hill School of Medicine. UNC HIV Cure Center. Department of Medicine. Chapel Hill, NC, USA.
University of Southern California. Los Angeles, CA, USA.
HIV i-Base. London, UK.
Cornell University. Weill Cornell Medicine. New York, NY, USA.
Aidsfonds. Amsterdam, the Netherlands.
University Paris Saclay, AP-HP, Bicêtre Hospital, UMR1184 INSERM CEA, Le Kremlin Bicêtre. Paris, France.
International AIDS Society. Geneva, Switzerland.
Africa Health Research Institute and University of KwaZulu-Natal. Durban, South Africa / University College London. London, UK / Ragon Institute of MGH, MIT and Harvard University. Cambridge, MA, USA.
Berman Institute of Bioethics and Department of Medicine. Johns Hopkins University, Baltimore, MD, USA.
National Institute for Communicable Diseases and Faculty of Health Sciences, University of the Witwatersrand. Johannesburg, South Africa.
UZ Ghent. Ghent, Belgium.
Victorian Infectious Diseases Service, The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity. Melbourne, Australia. / Department of Infectious Diseases, Alfred Hospital and Monash University. Melbourne, Australia / 17Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity. Melbourne, Australia.
Fundação Oswaldo Cruz. Instituto Oswado Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
The International AIDS Society (IAS) Global Scientific Strategy working group.
University of North Carolina at Chapel Hill School of Medicine. UNC HIV Cure Center. Department of Medicine. Chapel Hill, NC, USA.
University of Southern California. Los Angeles, CA, USA.
HIV i-Base. London, UK.
Cornell University. Weill Cornell Medicine. New York, NY, USA.
Aidsfonds. Amsterdam, the Netherlands.
University Paris Saclay, AP-HP, Bicêtre Hospital, UMR1184 INSERM CEA, Le Kremlin Bicêtre. Paris, France.
International AIDS Society. Geneva, Switzerland.
Africa Health Research Institute and University of KwaZulu-Natal. Durban, South Africa / University College London. London, UK / Ragon Institute of MGH, MIT and Harvard University. Cambridge, MA, USA.
Berman Institute of Bioethics and Department of Medicine. Johns Hopkins University, Baltimore, MD, USA.
National Institute for Communicable Diseases and Faculty of Health Sciences, University of the Witwatersrand. Johannesburg, South Africa.
UZ Ghent. Ghent, Belgium.
Victorian Infectious Diseases Service, The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity. Melbourne, Australia. / Department of Infectious Diseases, Alfred Hospital and Monash University. Melbourne, Australia / 17Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity. Melbourne, Australia.
Fundação Oswaldo Cruz. Instituto Oswado Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
The International AIDS Society (IAS) Global Scientific Strategy working group.
Share